Sébastien Viel Rémi Pescarmona Alexandre Belot Audrey Nosbaum Christine Lombard Thierry Walzer Frédéric Bérard
10.3389/fimmu.2018.00110
Front Immunol
2018 Jan 29;9:110.
adcc antibody dependent cell cytotoxicity natural killer cells rasburicase type 2 hypersensitivity
CC BY
https://pubmed.ncbi.nlm.nih.gov/29434608/
Drug Hypersensitivity / diagnosis Gout Suppressants / adverse effects Killer Cells, Natural / immunology Urate Oxidase / adverse effects
Drug Hypersensitivity / diagnosis Gout Suppressants / adverse effects Killer Cells, Natural / immunology Urate Oxidase / adverse effects Case Reports Research Support, Non-U.S. Gov't Antibody-Dependent Cell Cytotoxicity / immunology Biological Assay Drug Hypersensitivity / immunology Humans Lymphocyte Activation Male Middle Aged Gout Suppressants rasburicase Urate Oxidase
PMC5796899
29434608
A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay
2018